Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 265 (TMEM265) is a poorly characterized multi-pass transmembrane protein predicted to localize to cellular membranes. It belongs to the CECR6/TMEM121 family by sequence homology and is evolutionarily conserved, including in zebrafish and other vertebrates. There are no data in the public domain supporting a receptor, transporter, or enzyme function, nor an association with established medical disorders, drug interactions, or known biomarker status. The gene encodes a protein of uncertain physiological role, and no comprehensive functional studies or evidence of therapeutic targeting have been published to date. Key details: - Gene location: Chromosome 16 in human (Ensembl: ENSG00000281991; NCBI Gene: 100862671) - Protein length: Human isoform A0A087WTH1 (Uniprot) ~378 amino acids - Family/Domains: Predicted member of the CECR6/TMEM121 family, other domains not characterized - Expression/pattern: No verified tissue specificity or disease linkage - Experimental Data: Largely missing for molecular function, pathway involvement, or clinical relevance
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 265 (TMEM265).